Trials / Completed
CompletedNCT03845387
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
A Phase II Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Objective of this study is to investigate the efficacy, safety and pharmacokinetics of KDT-3594 in patients with early Parkinson's disease without a concomitant medication of L-dopa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KDT-3594 | oral administration, dose titration |
| DRUG | Pramipexole | ER formulation, oral administration, dose titration |
Timeline
- Start date
- 2019-02-26
- Primary completion
- 2020-02-21
- Completion
- 2020-02-21
- First posted
- 2019-02-19
- Last updated
- 2021-02-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03845387. Inclusion in this directory is not an endorsement.